By
AmyT on
February 28, 2011
Recently I stumbled upon a firm based in Fort Lauderdale, FL, that calls itself Pancreum, “The Wearable Artificial Pancreas Company.” Wow. Really? There is such a thing already? I just had to investigate.
The company’s website describes a four-part system including a controller (PDA), a CGM sensor called the “GlucoWedge,” a small wireless insulin pump called the “BetaWedge,” a small wireless glucagon pump called the “AlphaWedge,” and a set of “iPancreum” software apps that manage…
Read more »
Hello everyone!
I wanted to take a few minutes today to introduce myself as the new assistant editor here at the ‘Mine. While I am not new to the diabetes community, some of you might not be as familiar with me as others and I wanted to make sure that we could all get to know each other.
I was diagnosed with type 1 diabetes nearly 17 years ago, on January 27, 1994 (funny how…
Read more »
By
AmyT on
March 18, 2010
I proudly present Samantha Katz as Exhibit A: the graduate student from Northwestern University who (along with project partner Erik Schickli) won last year’s DiabetesMine Design Challenge Grand Prize, and was subsequently hired by Medtronic Diabetes to help design their next-generation insulin pumps. (See yesterday’s big Medtronic announcement.) Samantha is living proof that “crowdsourcing” exercises like this contest can shake Pharma’s big tree.
This year, Samantha is one of our expert judges for the 2010…
Read more »
By
AmyT on
March 17, 2010
Happy St. Patrick’s Day, again. See this morning’s post with some wee silliness on that.
A quick newsflash on this lovely green day: this morning Medtronic has announced that it has received FDA approval for its new Paradigm Revel combination insulin pump/continuous glucose monitor, which they’re calling “the industry’s most advanced integrated system for diabetes management” (see product info here).
That may be an overstatement, considering the Revel does not include the automatic-suspend feature that…
Read more »
By
AmyT on
January 19, 2010
Last week, I spent a little bit of time at the JP Morgan Healthcare Conference, a nearly-thirty-year-old annual gathering that’s become “the health care industry’s premier financial event, giving more than 330 companies a chance to make formal pitches to institutional investors.” Due to a houseful of sickies at home, I wasn’t able to attend as many presentations as I’d have liked, but I did catch a few of the “biggies,” including the talk by…
Read more »
